Skip to main content

Table 1 Basic characteristics of the included studies

From: Are dopamine agonists still the first-choice treatment for prolactinoma in the era of endoscopy? A systematic review and meta-analysis

Study name

I/A/Ga

Interventionb

No.

Male/female

Meanage/y

Biochemical cure ratec

Recurrent rated

Duration 1

Duration 2

Duration 3

Study type

Adam 2013

mixed_p

endoscopic_s

17

NA

NA

8/17

NA

40

  

Case-series

Akira 2006

mixed_p

mixed_s

13

3/10

NA

NA

NA

NA

  

Case-series

Albert 1992

0/29/0

BRC

29

14/15

NA

NA

NA

NA

NA

NA

Non-RCT

Alessandro 2013

mixed_p

CAB

43

8/35

33.65

24/43

NA

NA

12

NA

Case-series

Alexander 2018

60/0/0

endoscopic_s

60

10/50

33.5

40/60

NA

37

  

Non-RCT

Amir 2007

12/13/0

endoscopic_s

25

NA

NA

21/25

NA

19

  

Case-series

Amit 2015

0/71/0

CAB

71

71/0

44.7

51/71

NA

80.3

NA

NA

Case-series

Andreja 2012

39/22/0

endoscopic_s

61

NA

NA

54/61

NA

NA

  

Case-series

Annamaria1 2004

mixed_p

CAB

20

20/0

34

20/20

NA

NA

NA

NA

Non-RCT

Annamaria2 2004

10/41/0

CAB

51

51/0

32.9

39/51

NA

24

  

Non-RCT

Annamaria 2007

115/79/0

CAB

194

NA

NA

NA

81/194

68.6

42.6

45.8

Case-series

Annamaria 1997

8/19/0

mixed_DA

27

NA

NA

23/27

NA

NA

NA

NA

Case-series

Annamaria 2000

0/45/0

mixed_DA

45

17/45

NA

40/45

NA

NA

NA

NA

Non-RCT

Antonell 2001

44/28/0

mixed_DA

188

NA

NA

138/188

NA

8.3

NA

NA

Non-RCT

Antonio 2007

mixed_p

mixed_s

65

20/45

36

42/65

6/42

56

  

Case-series

Arafah 1986

mixed_p

microscopic_s

120

0/120

27.9

96/120

NA

NA

  

Case-series

Archer 1982

17/0/0

BRC

17

0/17

NA

16/17

NA

24

24

NA

Case-series

Arijit 2005

0/15/14

BRC

29

29/0

31.9

NA

NA

NA

NA

NA

Case-series

Arimantas 2012

32/0/0

microscopic_s

32

0/32

31

19/32

NA

50.4

  

Case-series

Arturo 1979

mixed_p

BRC

14

0/14

29.71

10/14

NA

NA

NA

NA

Case-series

Asano 2001

mixed_p

mixed_t

13

NA

37.3

NA

NA

NA

  

Non-RCT

Ashu 2013

0/38/0

CAB

38

21/17

34.2

33/38

NA

16.1

NA

NA

RCT

Ashu 2012

0/38/0

CAB

38

NA

NA

30/38

NA

6

NA

NA

RCT

Barbara 2017

mixed_p

BRC

28

0/28

26

13/28

NA

NA

NA

NA

Case-series

Barbosa 2014

mixed_p

mixed_DA

21

NA

NA

17/21

NA

NA

6

NA

Non-RCT

Berezin 1995

mixed_p

mixed_t

75

75/0

NA

36/52

NA

NA

NA

NA

Case-series

Bevan 1987

mixed_p

mixed_s

67

19/48

32.4

34/67

NA

NA

  

Case-series

Bhansali 2010

0/15/0

CAB

15

NA

31.7

14/15

NA

NA

NA

NA

Case-series

Biswas 2005

89/0/0

mixed_DA

89

NA

NA

NA

57/89

37.2

37.2

21.6

Non-RCT

Cannavo 1999

26/11/0

CAB

37

5/32

NA

34/37

NA

NA

24

NA

Case-series

Carlo 1992

mixed_p

CAB

127

3/124

NA

114/127

NA

NA

14

NA

Case-series

Catarina 2018

0/67/0

mixed_DA

67

34/33

43

58/67

NA

NA

NA

NA

Case-series

Charpentier 1985

mixed_p

mixed_s

212

NA

NA

96/212

12/70

52.8

  

Case-series

Christine 2016

0/57/0

mixed_DA

57

30/27

37.5

NA

NA

NA

NA

NA

Non-RCT

Cintia 2011

mixed_p

mixed_DA

22

NA

NA

17/22

NA

NA

6

NA

Non-RCT

Coculescu 1983

mixed_p

BRC

22

NA

NA

19/22

NA

NA

10.1

NA

Case-series

Corsello 2003

0/0/10

CAB

10

NA

NA

5/10

NA

NA

38.9

NA

Case-series

Der-Yang 2002

mixed_p

mixed_s

44

1/43

46

32/44

NA

NA

  

RCT

Diane 2017

27/50/0

mixed_s

77

NA

NA

40/77

8/36

12

  

Case-series

Dogan 2015

42/0/0

CAB

42

NA

NA

NA

34/42

12

NA

NA

Non-RCT

Elise 1984

42/23/0

mixed_s

65

NA

NA

46/65

6/46

50

  

Case-series

Emir 2018

mixed_p

mixed_DA

25

18/7

39.96

NA

NA

NA

NA

NA

Non-RCT

Enrica 1989

mixed_p

mixed_s

22

1/21

NA

NA

NA

NA

  

Case-series

Erika1 2007

mixed_p

mixed_DA

31

0/31

33.0

NA

NA

NA

NA

NA

Non-RCT

Erika2 2007

mixed_p

mixed_DA

45

0/45

34.5

NA

NA

NA

NA

NA

Non-RCT

Esposito 2004

mixed_p

mixed_s

42

14/26

33.2

25/42

5/21

31

  

Case-series

Essais 2002

0/29/0

BRC

29

10/19

NA

27/29

NA

NA

NA

NA

Case-series

Etienne 1996

mixed_p

mixed_DA

10

2/8

NA

8/9

NA

NA

NA

NA

Non-RCT

Etienne 2009

0/122/0

CAB

122

50/72

NA

115/122

NA

NA

NA

NA

Case-series

Etual 2016

0/152/47

mixed_DA

199

114/85

40.9

145/199

NA

NA

NA

NA

Non-RCT

Eun-Hee 2009

0/10/0

CAB

10

10/0

37

6/10

NA

NA

19

NA

Case-series

Fadi 1996

mixed_p

mixed_s

64

NA

NA

59/64

25/59

147.6

  

Case-series

Ferrari 1997

0/85/0

CAB

85

NA

NA

52/85

NA

NA

NA

NA

Case-series

Frederick 2018

mixed_p

endoscopic_s

79

22/57

35.8

65/79

NA

NA

  

Non-RCT

Fritz 1985

13/11/0

mixed_s

24

0/24

29.7

NA

14/24

NA

  

Case-series

Giorgio 2006

28/38/0

endoscopic_s

66

NA

NA

50/66

NA

NA

  

Case-series

Giulio 1989

mixed_p

mixed_s

119

0/119

NA

73/119

5/40

NA

  

Case-series

Hae-Dong 2001

mixed_p

endoscopic_s

35

NA

NA

24/35

NA

NA

  

Case-series

Hae-Dong 1997

mixed_p

endoscopic_s

15

2/13

32.2

10/15

NA

NA

  

Case-series

Hamilton 2005

mixed_p

mixed_s

79

NA

NA

34/79

NA

NA

  

Non-RCT

Hancock 1980

mixed_p

BRC

36

NA

NA

28/36

NA

NA

NA

NA

Case-series

Helen 1999

32/0/0

mixed_s

32

0/32

NA

25/32

1/25

70

  

Case-series

Hidemitsu 2001

mixed_p

microscopic_s

13

NA

NA

NA

NA

NA

  

Case-series

Hidetoshi 2013

mixed_p

mixed_s

138

NA

NA

105/138

5/81

144

  

Case-series

Hildebrandt 1989

0/10/0

BRC

10

NA

NA

3/10

NA

NA

1

NA

Case-series

Hildebrandt 1992

mixed_p

mixed_DA

14

NA

NA

10/14

NA

NA

NA

NA

Non-RCT

Hofstetter 2011

32/53/0

endoscopic_s

85

NA

NA

51/85

NA

NA

  

Case-series

Huda 2010

40/0/0

mixed_DA

40

1/39

NA

NA

31/40

58

108

58

Case-series

Ilan 2007

0/0/10

CAB

10

10/0

38.2

9/10

NA

NA

NA

NA

Case-series

Ilan 2016

0/0/18

mixed_DA

18

16/2

36.3

11/18

NA

NA

NA

NA

Case-series

Ilan 2019

mixed_p

mixed_DA

28

28/0

71.3

24/27

NA

NA

NA

NA

Case-series

Ivan 2015

40/38/0

mixed_t

78

23/55

39.8

44/78

NA

NA

25

NA

Non-RCT

Jackson 2010

7/34/0

endoscopic_s

41

NA

NA

34/41

3/35

NA

  

Case-series

Jae 2009

mixed_p

mixed_t

117

31/86

35.1

103/117

NA

NA

NA

NA

Case-series

Johanna 1991

0/12/0

BRC

12

8/4

42.2

NA

11/12

12

58.8

4.3

Case-series

Johanna 1990

0/19/0

BRC

19

12/7

NA

16/19

NA

40.8

40.8

NA

Case-series

Jonathan 1992

mixed_p

mixed_s

82

7/75

30.5

65/82

5/65

51.7

  

Case-series

Katarina 2011

mixed_p

mixed_DA

14

6/8

39.7

14/14

NA

NA

6

NA

Case-series

Kharlip 2009

mixed_p

CAB

46

NA

NA

NA

25/46

NA

NA

3

Case-series

Kiyoshi 1984

mixed_p

mixed_s

12

NA

NA

NA

NA

NA

  

Case-series

Kreutzer 2008

mixed_p

mixed_s

212

133/79

36

102/212

17/91

NA

  

Non-RCT

Kristof 2002

mixed_p

mixed_s

37

16/21

31

10/37

2/10

44.4

  

Case-series

Kyung 2013

mixed_p

BRC

23

17/6

48

16/23

NA

NA

30

NA

Case-series

Liang 2018

0/0/42

mixed_t

42

NA

NA

21/42

NA

NA

NA

NA

Non-RCT

Lukas 2017

mixed_p

mixed_t

107

0/107

34

65/107

NA

NA

NA

NA

Non-RCT

Marco 2002

mixed_p

mixed_s

120

27/93

29.7

77/120

13/77

50.2

  

Case-series

Margarida 2017

mixed_p

mixed_DA

50

5/45

35.1

NA

14/50

NA

119.3

NA

Non-RCT

Maria 2015

mixed_p

mixed_DA

29

NA

NA

29/29

NA

NA

NA

NA

Case-series

María Martín 2013

47/0/0

mixed_DA

47

NA

30

39/47

NA

NA

NA

NA

Case-series

Mario 2017

24/0/0

mixed_s

24

5/19

34.8

8/24

1/8

NA

  

Non-RCT

Masami 2010

mixed_p

CAB

85

NA

NA

85/85

NA

NA

NA

NA

Case-series

Mia-Maiken 2013

mixed_p

mixed_DA

12

5/7

39.7

8/12

NA

NA

NA

NA

Case-series

Michael 2009

mixed_p

mixed_s

176

20/156

31

NA

NA

NA

  

Non-RCT

Miguel 1982

mixed_p

microscopic_s

100

NA

NA

68/100

5/68

NA

  

Case-series

Moon 2011

mixed_p

BRC

36

25/11

NA

29/36

NA

NA

NA

NA

Case-series

Muratori 1997

26/0/0

CAB

26

0/26

NA

25/26

13/19

12

12

NA

Case-series

Muriel 2011

24/10/0

microscopic_s

34

4/30

NA

32/34

2/32

33.5

  

Case-series

Mussa 2015

0/0/16

CAB

16

10/6

34.9

6/16

NA

NA

NA

NA

Case-series

Myoung 2017

30/59/0

mixed_DA

89

27/62

33.7

NA

51/89

25.8

28.9

NA

Case-series

Na 2018

31/32/0

mixed_s

63

NA

57

48/63

3/48

53

  

Case-series

Naguib 1986

mixed_p

mixed_t

190

0/190

28.6

NA

NA

NA

28.8

NA

Non-RCT

Nazir 2015

mixed_p

CAB

19

1/18

27.3

18/19

NA

NA

NA

NA

Non-RCT

Niki 2013

0/12/0

CAB

12

11/1

40.5

11/12

NA

NA

NA

NA

Case-series

Nissim 1982

0/7/0

BRC

7

NA

NA

4/7

NA

NA

NA

NA

Case-series

Oksana 2018

0/0/68

mixed_t

68

60/8

41.5

35/68

NA

NA

104.7

NA

Case-series

Oluwaseun 2019

mixed_p

mixed_DA

69

NA

NA

29/69

NA

6

NA

NA

Case-series

Omar 1983

28/16/0

mixed_s

44

0/44

26.8

29/44

16/29

41.5

  

Case-series

Paepegaey 2017

0/260/0

CAB

260

135/125

36.2

157/260

14/35

NA

NA

NA

Case-series

Paluzzi 2013

11/42/0

endoscopic_s

53

NA

NA

42/53

NA

NA

  

Case-series

Panagiotis 2011

mixed_p

mixed_DA

79

17/62

35.3

NA

11/26

49

79

NA

Case-series

Paul 1983

mixed_p

mixed_s

40

0/40

NA

25/40

9/25

23

  

Case-series

Pelkonen 1981

mixed_p

mixed_s

60

15/45

NA

NA

NA

NA

  

Case-series

Pietro 2005

mixed_p

mixed_s

151

NA

NA

93/151

NA

NA

  

Case-series

Raverot 2010

mixed_p

mixed_s

94

32/62

37.8

60/94

19/60

138

  

Case-series

Renata 2013

mixed_p

CAB

61

13/48

34.4

57/61

NA

60

60

NA

Case-series

Renata 2015

mixed_p

CAB

32

32/0

42

31/32

NA

24

24

NA

Non-RCT

Ronald 1982

22/14/0

mixed_s

36

NA

NA

NA

1/35

NA

  

Case-series

Rudolf 1985

27/0/0

microscopic_s

27

NA

NA

19/27

NA

NA

  

Case-series

Safak 2016

0/113/0

endoscopic_s

113

NA

NA

51/113

NA

36

  

Case-series

Safak 2016

19/0/10

endoscopic_s

29

NA

NA

15/29

NA

36

   

Sandhya 2018

mixed_p

mixed_DA

28

0/28

NA

16/18

5/16

12

216

36

Case-series

Sandhya 2017

mixed_p

mixed_DA

16

0/16

NA

15/16

NA

NA

NA

NA

Case-series

Schlechte 1985

mixed_p

microscopic_s

68

0/68

NA

37/68

12/37

60.00

  

Case-series

Sema 2016

mixed_p

mixed_DA

67

17/50

NA

NA

31/67

108.8

76.9

16.1

Non-RCT

Sema 2018

mixed_p

mixed_DA

308

NA

71

NA

NA

NA

NA

NA

Non-RCT

Shigetoshi 2009

17/12/0

endoscopic_s

29

NA

NA

21/29

NA

NA

  

Case-series

Shrikrishna 2009

mixed_p

mixed_DA

39

9/30

NA

14/39

NA

NA

NA

NA

Case-series

Shrikrishna 2010

0/0/10

CAB

10

5/5

36.1

8/10

NA

NA

NA

NA

Case-series

Steven 1996

11/23/0

mixed_s

34

8/26

23.3

9/34

NA

NA

  

Case-series

Taizo 1991

mixed_p

mixed_s

35

0/35

NA

22/35

NA

NA

  

Case-series

Takakazu 2002

mixed_p

mixed_s

32

12/20

32

14/32

NA

NA

  

Case-series

Tevfik 2001

mixed_p

mixed_DA

34

4/30

33.1

24/34

NA

NA

NA

NA

RCT

Thomas 2011

45/15/0

mixed_DA

60

NA

NA

NA

43/60

65

59

6

Case-series

Thomson 1985

mixed_p

microscopic_s

77

NA

NA

53/77

NA

NA

  

Case-series

Timothy 2015

mixed_p

endoscopic_s

66

22/44

36.7

45/66

NA

12

  

Case-series

Vanessa 2012

mixed_p

mixed_s

63

18/45

31

29/63

10/29

36

  

Case-series

Verena 2017

mixed_p

CAB

53

31/22

40

NA

NA

NA

9

NA

Case-series

Wang 1987

mixed_p

BRC

24

NA

NA

NA

19/24

40.8

58.8

NA

Case-series

Wang 2015

132/176/0

endoscopic_s

308

NA

NA

261/308

NA

NA

  

Case-series

Winnie 2018

mixed_p

mixed_s

31

31/0

40.8

NA

NA

41.9

  

Case-series

Wolfsberger 2003

0/11/0

mixed_s

11

11/0

41

8/11

NA

84

  

Case-series

Xin 2011

mixed_p

mixed_s

87

87/0

38

46/87

9/45

45

  

Case-series

Yan 2015

mixed_p

mixed_s

99

NA

NA

71/99

NA

NA

  

Case-series

Yang 2015

mixed_p

mixed_s

9

5/4

NA

NA

NA

NA

  

Case-series

Yan-Long 2018

mixed_p

endoscopic_s

52

14/38

37.69

40/52

6/40

13.5

  

Case-series

Yi 2018

mixed_p

mixed_s

36

11/25

NA

34/36

NA

NA

  

Case-series

Yi-Jun 2017

mixed_p

microscopic_s

184

184/0

36.3

57/187

NA

NA

  

Case-series

Youichi 1986

mixed_p

microscopic_s

98

16/82

31

45/98

NA

NA

  

Case-series

Youngki 2014

0/44/0

mixed_DA

44

28/16

36.8

34/44

NA

NA

NA

NA

Case-series

  1. aI/A/G: numbers of patients with microprolactinoma/macroprolactinoma/giant prolactinoma; mixed_p: mixed_prolactinoma, data of this part is inseparable, which includes patients with macroprolactinoma, microprolactinoma, and giant prolactinoma; bmixed_t: mixed treatment,treatments within this study include DAs and surgery and data of each treatment is available; mixed_s: mixed_surgery, data include patients with microscopic surgery and endoscopic surgery; microscopic_s: microscopic_surgery; endoscopic_s: endoscopic_surgery; DAs: dopamine agonists; BRC: bromocriptine; CAB: cabergoline; c cured/treated; d replased/cured; e mean follow up duration months; NA not applicable, because the data was not provided by included studies. Duration 1: follow up duration (month); Duration 2: DAs treatment duration (month), only for studies with DAs; Duration 3: follow-up duration after DAs withdrawal (month), only for studies with DAs; No.: sample size of included study